Searched for
JAPAN DRUGMAKERS
Tariff therapy: Trump nudges pharma cos to make drugs in US or face 100% tariffAmerica is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...03 Apr, 2026, 01.14 AM IST- Global Markets | Japan's Nikkei falls as US-Iran tensions unsettle investorsJapan's Nikkei share average fell on Friday as heightened U.S.-Iran tensions and a sell-off in U.S. private-equity shares dented sentiment.20 Feb, 2026, 01.41 PM IST
- TrumpRx: Japanese drugmakers slump after Trump unveils discount drug websiteShares of Japanese pharmaceutical companies fell sharply in early Tokyo trading after the launch of TrumpRx, a U.S. website offering discou...06 Feb, 2026, 06.29 AM IST
- Heavyweights pull Nikkei lower, Topix gains on drugmakers' boostNikkei inched down 0.2 per cent to close at 28,963.56, while the Topix edged up 0.1 per cent at 1,962.65.08 Jun, 2021, 01.40 PM IST
- India's Dr.Reddy's ends study of COVID-19 drug Avigan in KuwaitData from the Kuwait trial, conducted in partnership with United Arab Emirates-based medical alliance Global Response Aid FZCO (GRA), showe...27 Jan, 2021, 03.15 PM IST
- Japan stocks end higher on gains in drugmakers, tech stocksThe Nikkei 225 Index rose 0.33 per cent to 26,524.79, while the broader Topix rose 0.23 per cent to 1,765.21.23 Dec, 2020, 02.16 PM IST
- Pfizer applies for COVID-19 vaccine approval in JapanDrugmaker Pfizer Inc said on Friday it had applied for approval in Japan for its COVID-19 vaccine, which is already being administered in t...18 Dec, 2020, 02.20 PM IST
- As outage ends, Nikkei plunges after Trump catches coronavirusA day after all share trading was suspended due to a system glitch, Nikkei lost 0.67% to 23,029.90, its lowest close in five weeks, though ...02 Oct, 2020, 01.17 PM IST
- India's Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patientsDrugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreat...29 May, 2020, 04.37 PM IST
- Glenmark Pharma to study potential Covid-19 drug combinationThe study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...26 May, 2020, 04.19 PM IST
- Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brandsThe acquisition will result in a wider offering for Lupin in Japanese market where its sales last fiscal stood at Rs 1,364 crore.27 Jul, 2016, 05.27 AM IST
- Sun Pharmaceutical banks on Daiichi Sankyo to crack Japan marketSun Pharma will soon put its purchase to work through the exclusive marketing opportunity offered by two drugs in US, rationalising researc...11 Aug, 2014, 04.53 AM IST
- Lupin files second suit against RanbaxyMumbai-based drugmaker Lupin has filed a second suit in the US against Ranbaxy Laboratories to prevent the country’s largest drugmaker from...06 Apr, 2011, 05.02 AM IST
- Abbott, Ranbaxy settle patent suitThe financial upside for Ranbaxy will depend on several factors since there are 3 other drugmakers wanting to launch their versions of the ...19 Feb, 2011, 01.22 AM IST
- Drug market grows 20% in H1; foreign firms tighten holdA series of buyouts by foreign heavy weights, including Ranbaxy and Piramal Healthcare has resulted in foreign MNCs taking three slots amon...09 Aug, 2010, 03.46 AM IST
- Pfizer to spend 300 mn dlr on R&D in KoreaPfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...13 Jun, 2007, 12.53 PM IST
- Pfizer to spend 300 mn dlr on R&D in KoreaPfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...13 Jun, 2007, 12.43 PM IST
Load More
